MED Stock Overview
Medcomtech, S.A. distributes products in the areas of orthopedic surgery, traumatology, neurosurgery, pain, and anesthesia worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medcomtech, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.69 |
| 52 Week High | €0.69 |
| 52 Week Low | €0.28 |
| Beta | 0.58 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 56.82% |
| 3 Year Change | -45.67% |
| 5 Year Change | -61.88% |
| Change since IPO | -84.32% |
Recent News & Updates
Returns Are Gaining Momentum At Medcomtech (BME:MED)
Oct 18
Many Still Looking Away From Medcomtech, S.A. (BME:MED)
Aug 26Returns At Medcomtech (BME:MED) Are On The Way Up
Mar 21Medcomtech (BME:MED) Is Experiencing Growth In Returns On Capital
Dec 06Recent updates
Returns Are Gaining Momentum At Medcomtech (BME:MED)
Oct 18Many Still Looking Away From Medcomtech, S.A. (BME:MED)
Aug 26Returns At Medcomtech (BME:MED) Are On The Way Up
Mar 21Medcomtech (BME:MED) Is Experiencing Growth In Returns On Capital
Dec 06Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To Persist
Aug 16Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On Capital
Apr 09Here's Why Medcomtech (BME:MED) Can Afford Some Debt
May 17Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Nov 30
Shareholder Returns
| MED | ES Healthcare | ES Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | -0.9% |
| 1Y | 56.8% | 2.5% | 11.1% |
Return vs Industry: MED exceeded the Spanish Healthcare industry which returned -8.4% over the past year.
Return vs Market: MED exceeded the Spanish Market which returned 11.4% over the past year.
Price Volatility
| MED volatility | |
|---|---|
| MED Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.3% |
| Market Average Movement | 3.2% |
| 10% most volatile stocks in ES Market | 5.6% |
| 10% least volatile stocks in ES Market | 0.6% |
Stable Share Price: MED has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MED's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 124 | Juan Sagales Manas | www.medcomtech.es |
Medcomtech, S.A. distributes products in the areas of orthopedic surgery, traumatology, neurosurgery, pain, and anesthesia worldwide. It engages in consulting, intermediation, manufacturing, retail, and wholesale trade of medical-surgical devices and instruments. The company offers products and solutions for joint replacement, upper extremity, sports medicine, lower extremity, spine, external fixation, trauma, custom made implants, spacers, regenerative solutions, pain management, hospital line, and cements and accessories.
Medcomtech, S.A. Fundamentals Summary
| MED fundamental statistics | |
|---|---|
| Market cap | €8.94m |
| Earnings (TTM) | -€1.46m |
| Revenue (TTM) | €27.36m |
0.3x
P/S Ratio-6.1x
P/E RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MED income statement (TTM) | |
|---|---|
| Revenue | €27.36m |
| Cost of Revenue | €8.68m |
| Gross Profit | €18.68m |
| Other Expenses | €20.14m |
| Earnings | -€1.46m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 68.27% |
| Net Profit Margin | -5.35% |
| Debt/Equity Ratio | 7,076.7% |
How did MED perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/13 20:25 |
| End of Day Share Price | 2024/01/15 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medcomtech, S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Thomas Cooper | Edison Investment Research |
| Natalia Bjork | Kepler Capital Markets |